Gabapentin
Product Images NDC 10544-447

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 10544-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (A58e76e8 0645 4c40 A738 5015e88bd68c 01)

FDA Label Image

Figure 1 (A58e76e8 0645 4c40 A738 5015e88bd68c 02)

Figure 1 (A58e76e8 0645 4c40 A738 5015e88bd68c 02)
This is a chart showing the Mean Pain Score over a 4-week Dose Titration Period and 4-week Fixed Dose Period, with Placebo and Gabapentin at 3600 mg/day. The chart includes Baseline and 8 weeks.*
FDA Label Image

Figure 2 (A58e76e8 0645 4c40 A738 5015e88bd68c 03)

Figure 2 (A58e76e8 0645 4c40 A738 5015e88bd68c 03)
This is a graph showing the mean pain score for a study with a 3-week dose titration period and a 4-week fixed dose period. The study included a placebo group and two groups taking different doses of Gabapentin. The x-axis shows the weeks of the study and the y-axis shows the mean pain score.*
FDA Label Image

Figure 3 (A58e76e8 0645 4c40 A738 5015e88bd68c 04)

Figure 3 (A58e76e8 0645 4c40 A738 5015e88bd68c 04)
The text seems to be presenting data related to a clinical trial study (Study 1) and shows the percentage of responders at some endpoint. The data is presented in a table/chart format with percentages ranging from 10% to 50+. The significance values of the results are also mentioned with the text "* p<0.01" and "5% p <0,001". Furthermore, there is a mention of 254 participants involved in the study.*
FDA Label Image

Figure 4 (A58e76e8 0645 4c40 A738 5015e88bd68c 05)

FDA Label Image

Label Graphic-gabapentin (blenheim) 300mg 90s (A58e76e8 0645 4c40 A738 5015e88bd68c 06)

Label Graphic-gabapentin (blenheim) 300mg 90s (A58e76e8 0645 4c40 A738 5015e88bd68c 06)
This is a description of Gabapentin capsules marked with NDC number 10544-436-90 and LCN number 000. The capsules are manufactured by Apotex Corp with a dosage strength of 300mg. There are 90 capsules in each pack that are only available with a prescription from a certified physician. The capsules should be stored in a container that is tight and light-resistant, and kept out of reach of children. The lot number for the capsules is BPO00O000D, and the expiry date is 00/00/0000. There is additional information about other Gabapentin capsules in varying quantities with lot numbers and expiry dates.*
FDA Label Image

Label Graphic-gabapentin (blenheim) 400mg 90s (A58e76e8 0645 4c40 A738 5015e88bd68c 07)

Label Graphic-gabapentin (blenheim) 400mg 90s (A58e76e8 0645 4c40 A738 5015e88bd68c 07)
Gabapentin Capsules, USP 400mg, in a package of 90 capsules, with the NDC code 10544-447-90 and LCN# oo0, manufactured by Apotex Corp. and with a lot number BPODOOODOO, is a prescription medicine. The dosage is not available due to a damaged package but a suitable temperature is advised. The medication is permitted to be stored at temperatures of up to 150 0% aGE B. This medication is indicated for the treatment of certain types of seizures and neuropathic pain. The expiration date of the product is 00/00/0000.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.